Khan mohd shadab (16 risultati)

Soft cover. Condizione: New. ISBN:9788130930343.

Condizione: New. pp. 454.

Soft cover. Condizione: New. ISBN:9789387925649.

Condizione: New. pp. 563 Index 1st Edition.

Paperback. Condizione: Brand New. 80 pages. 8.66x5.91x0.19 inches. In Stock.

Condizione: New. pp. 272.

Taschenbuch. Condizione: Neu. TRIPs and Indian Pharmaceautical Industry | Mohd. Shadab Khan | Taschenbuch | 272 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9783659445309 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

Condizione: New. Print on Demand pp. 563.

Condizione: New. PRINT ON DEMAND pp. 563.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Aslam MohdDr. Mohd Aslam is an astute researcher and a promising physician. He is currently working as an Assistant Professor in the department of Medicine at Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Indi.…

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In order to conform to TRIPs agreement of WTO, the Indian Government amended the Indian Patent Act, 1970. Under the new product patent law, Indian drug makers can no longer manufacture and market reverse-engineered versions of drugs patented by foreign drug producers. The present study is an attempt to analyze possible impact of TRIPs Agreement on Indian pharmaceutical industry. This book is divided into five chapters. The first chapter is introductory in nature that provides statement of the problem. The second chapter presents an overview of Indian pharma industry. The third chapter attempts to highlights the main provisions of TRIPs and Indian Patent Act 1970. The fourth chapter attempts to assess the impact of TRIPs on Indian Pharmaceutical Industry. Finally, the fifth chapter discusses the main findings of the study and gives suggestions for strengthening the Indian pharma industry. This book will be useful to the government of India, policy makers, IPR professionals, drugs manufacturers, investors and students. 272 pp. Englisch.…

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Khan Mohd. ShadabDr. Mohd. Shadab Khan, M.Com, MBA, Ph.D (International Trade): Studied Commerce at Aligarh Muslim University (AMU), Aligarh, India. Assistant Professor at MIIT, Meerut, India.In order to conform to TRIPs agreemen.…

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In order to conform to TRIPs agreement of WTO, the Indian Government amended the Indian Patent Act, 1970. Under the new product patent law, Indian drug makers can no longer manufacture and market reverse-engineered versions of drugs patented by foreign drug producers. The present study is an attempt to analyze possible impact of TRIPs Agreement on Indian pharmaceutical industry. This book is divided into five chapters. The first chapter is introductory in nature that provides statement of the problem. The second chapter presents an overview of Indian pharma industry. The third chapter attempts to highlights the main provisions of TRIPs and Indian Patent Act 1970. The fourth chapter attempts to assess the impact of TRIPs on Indian Pharmaceutical Industry. Finally, the fifth chapter discusses the main findings of the study and gives suggestions for strengthening the Indian pharma industry. This book will be useful to the government of India, policy makers, IPR professionals, drugs manufacturers, investors and students.…

Condizione: New. Print on Demand pp. 272 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.

Condizione: New. PRINT ON DEMAND pp. 272.

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In order to conform to TRIPs agreement of WTO, the Indian Government amended the Indian Patent Act, 1970. Under the new product patent law, Indian drug makers can no longer manufacture and market reverse-engineered versions of drugs patented by foreign drug producers. The present study is an attempt to analyze possible impact of TRIPs Agreement on Indian pharmaceutical industry. This book is divided into five chapters. The first chapter is introductory in nature that provides statement of the problem. The second chapter presents an overview of Indian pharma industry. The third chapter attempts to highlights the main provisions of TRIPs and Indian Patent Act 1970. The fourth chapter attempts to assess the impact of TRIPs on Indian Pharmaceutical Industry. Finally, the fifth chapter discusses the main findings of the study and gives suggestions for strengthening the Indian pharma industry. This book will be useful to the government of India, policy makers, IPR professionals, drugs manufacturers, investors and students.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 272 pp. Englisch.…